MuLeVaClin - Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis

Leishmaniasis was declared at the 60th WHO Assembly (2007) one of the world’s most neglected diseases. Leishmaniasis affects largely the poorest of the poor, mainly in developing countries as India, Bangladesh, Sudan, Ethiopia and Latin America. Existing treatments have severe drawbacks: side…

01.11.2013 - 30.09.2018
Clinical Trial
European Commission (EU) / 7th Framework programme